Group Calls for Ban of Abbott’s ADD Drug
A 30-year-old Abbott Laboratories Inc. drug for attention deficit disorder poses an unacceptable risk of deadly liver damage and should be banned immediately, a U.S. consumer group said on Thursday.
Abbott sells the drug under the brand name Cylert, and generic companies sell a copycat version known as pemoline. Public Citizen said the drug had caused 21 cases of liver failure, including 13 that were fatal or required transplants.
(No Ratings Yet)
Loading ...You can skip to the end and leave a response. Pinging is currently not allowed.
Join the Conversation! Post a Comment:
Last reviewed: By John M. Grohol, Psy.D. on 25 Mar 2005
